STANDEX INTERNATIONAL CORP (SXI) Fundamental Analysis & Valuation

NYSE:SXI • US8542311076

Current stock price

276.49 USD
-2.4 (-0.86%)
At close:
276.49 USD
0 (0%)
After Hours:

This SXI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. SXI Profitability Analysis

1.1 Basic Checks

  • SXI had positive earnings in the past year.
  • SXI had a positive operating cash flow in the past year.
  • In the past 5 years SXI has always been profitable.
  • In the past 5 years SXI always reported a positive cash flow from operatings.
SXI Yearly Net Income VS EBIT VS OCF VS FCFSXI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

1.2 Ratios

  • SXI has a Return On Assets (3.47%) which is in line with its industry peers.
  • SXI has a Return On Equity (7.69%) which is comparable to the rest of the industry.
  • Looking at the Return On Invested Capital, with a value of 8.26%, SXI is in the better half of the industry, outperforming 63.36% of the companies in the same industry.
  • SXI had an Average Return On Invested Capital over the past 3 years of 9.23%. This is in line with the industry average of 10.00%.
Industry RankSector Rank
ROA 3.47%
ROE 7.69%
ROIC 8.26%
ROA(3y)8.13%
ROA(5y)6.95%
ROE(3y)14.16%
ROE(5y)12.39%
ROIC(3y)9.23%
ROIC(5y)9.14%
SXI Yearly ROA, ROE, ROICSXI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • SXI has a Profit Margin (6.20%) which is comparable to the rest of the industry.
  • SXI's Profit Margin has improved in the last couple of years.
  • SXI's Operating Margin of 16.32% is fine compared to the rest of the industry. SXI outperforms 75.57% of its industry peers.
  • SXI's Operating Margin has improved in the last couple of years.
  • SXI's Gross Margin of 41.03% is fine compared to the rest of the industry. SXI outperforms 76.34% of its industry peers.
  • SXI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 16.32%
PM (TTM) 6.2%
GM 41.03%
OM growth 3Y4.27%
OM growth 5Y6.87%
PM growth 3Y-5.45%
PM growth 5Y16.13%
GM growth 3Y2.82%
GM growth 5Y2.28%
SXI Yearly Profit, Operating, Gross MarginsSXI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

5

2. SXI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SXI is destroying value.
  • Compared to 1 year ago, SXI has more shares outstanding
  • The number of shares outstanding for SXI has been reduced compared to 5 years ago.
  • Compared to 1 year ago, SXI has a worse debt to assets ratio.
SXI Yearly Shares OutstandingSXI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
SXI Yearly Total Debt VS Total AssetsSXI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 4.50 indicates that SXI is not in any danger for bankruptcy at the moment.
  • SXI's Altman-Z score of 4.50 is fine compared to the rest of the industry. SXI outperforms 68.70% of its industry peers.
  • SXI has a debt to FCF ratio of 10.36. This is a negative value and a sign of low solvency as SXI would need 10.36 years to pay back of all of its debts.
  • SXI has a Debt to FCF ratio (10.36) which is comparable to the rest of the industry.
  • SXI has a Debt/Equity ratio of 0.76. This is a neutral value indicating SXI is somewhat dependend on debt financing.
  • SXI has a Debt to Equity ratio of 0.76. This is in the lower half of the industry: SXI underperforms 70.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF 10.36
Altman-Z 4.5
ROIC/WACC0.8
WACC10.31%
SXI Yearly LT Debt VS Equity VS FCFSXI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.3 Liquidity

  • SXI has a Current Ratio of 2.87. This indicates that SXI is financially healthy and has no problem in meeting its short term obligations.
  • SXI has a Current ratio of 2.87. This is in the better half of the industry: SXI outperforms 76.34% of its industry peers.
  • SXI has a Quick Ratio of 2.10. This indicates that SXI is financially healthy and has no problem in meeting its short term obligations.
  • SXI has a Quick ratio of 2.10. This is amongst the best in the industry. SXI outperforms 80.15% of its industry peers.
Industry RankSector Rank
Current Ratio 2.87
Quick Ratio 2.1
SXI Yearly Current Assets VS Current LiabilitesSXI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

6

3. SXI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 16.41% over the past year.
  • Measured over the past years, SXI shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.81% on average per year.
  • Looking at the last year, SXI shows a very strong growth in Revenue. The Revenue has grown by 21.02%.
  • Measured over the past years, SXI shows a small growth in Revenue. The Revenue has been growing by 5.50% on average per year.
EPS 1Y (TTM)16.41%
EPS 3Y10.17%
EPS 5Y16.81%
EPS Q2Q%8.9%
Revenue 1Y (TTM)21.02%
Revenue growth 3Y2.42%
Revenue growth 5Y5.5%
Sales Q2Q%16.6%

3.2 Future

  • SXI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.31% yearly.
  • The Revenue is expected to grow by 9.30% on average over the next years. This is quite good.
EPS Next Y13.51%
EPS Next 2Y15.19%
EPS Next 3Y19.31%
EPS Next 5YN/A
Revenue Next Year14.84%
Revenue Next 2Y10.37%
Revenue Next 3Y9.3%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SXI Yearly Revenue VS EstimatesSXI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
SXI Yearly EPS VS EstimatesSXI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

2

4. SXI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 33.31, which means the current valuation is very expensive for SXI.
  • The rest of the industry has a similar Price/Earnings ratio as SXI.
  • SXI's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.71.
  • Based on the Price/Forward Earnings ratio of 26.55, the valuation of SXI can be described as expensive.
  • The rest of the industry has a similar Price/Forward Earnings ratio as SXI.
  • SXI is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 38.09, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 33.31
Fwd PE 26.55
SXI Price Earnings VS Forward Price EarningsSXI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SXI is valued a bit more expensive than 61.07% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, SXI is valued a bit more expensive than 64.12% of the companies in the same industry.
Industry RankSector Rank
P/FCF 64.93
EV/EBITDA 21.04
SXI Per share dataSXI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of SXI may justify a higher PE ratio.
  • A more expensive valuation may be justified as SXI's earnings are expected to grow with 19.31% in the coming years.
PEG (NY)2.47
PEG (5Y)1.98
EPS Next 2Y15.19%
EPS Next 3Y19.31%

6

5. SXI Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.50%, SXI is not a good candidate for dividend investing.
  • SXI's Dividend Yield is comparable with the industry average which is at 1.08.
  • Compared to an average S&P500 Dividend Yield of 1.81, SXI's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.5%

5.2 History

  • The dividend of SXI is nicely growing with an annual growth rate of 7.88%!
  • SXI has paid a dividend for at least 10 years, which is a reliable track record.
  • SXI has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)7.88%
Div Incr Years15
Div Non Decr Years15
SXI Yearly Dividends per shareSXI Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • 28.95% of the earnings are spent on dividend by SXI. This is a low number and sustainable payout ratio.
  • SXI's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP28.95%
EPS Next 2Y15.19%
EPS Next 3Y19.31%
SXI Yearly Income VS Free CF VS DividendSXI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
SXI Dividend Payout.SXI Dividend Payout, showing the Payout Ratio.SXI Dividend Payout.PayoutRetained Earnings

SXI Fundamentals: All Metrics, Ratios and Statistics

STANDEX INTERNATIONAL CORP

NYSE:SXI (4/21/2026, 8:14:14 PM)

After market: 276.49 0 (0%)

276.49

-2.4 (-0.86%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)01-29
Earnings (Next)04-30
Inst Owners103.44%
Inst Owner Change-0.07%
Ins Owners2.11%
Ins Owner Change0.26%
Market Cap3.35B
Revenue(TTM)868.58M
Net Income(TTM)53.88M
Analysts84.44
Price Target277.7 (0.44%)
Short Float %5.04%
Short Ratio3.27
Dividend
Industry RankSector Rank
Dividend Yield 0.5%
Yearly Dividend1.27
Dividend Growth(5Y)7.88%
DP28.95%
Div Incr Years15
Div Non Decr Years15
Ex-Date02-13
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.09%
Min EPS beat(2)3.37%
Max EPS beat(2)4.8%
EPS beat(4)4
Avg EPS beat(4)4.15%
Min EPS beat(4)0.82%
Max EPS beat(4)7.6%
EPS beat(8)7
Avg EPS beat(8)4.31%
EPS beat(12)11
Avg EPS beat(12)4.11%
EPS beat(16)15
Avg EPS beat(16)3.86%
Revenue beat(2)0
Avg Revenue beat(2)-0.21%
Min Revenue beat(2)-0.32%
Max Revenue beat(2)-0.11%
Revenue beat(4)2
Avg Revenue beat(4)0.83%
Min Revenue beat(4)-0.32%
Max Revenue beat(4)3.02%
Revenue beat(8)2
Avg Revenue beat(8)-1.08%
Revenue beat(12)4
Avg Revenue beat(12)-0.81%
Revenue beat(16)7
Avg Revenue beat(16)-0.69%
PT rev (1m)0%
PT rev (3m)5.01%
EPS NQ rev (1m)-0.33%
EPS NQ rev (3m)-0.88%
EPS NY rev (1m)-0.73%
EPS NY rev (3m)-0.93%
Revenue NQ rev (1m)-0.33%
Revenue NQ rev (3m)0.42%
Revenue NY rev (1m)-0.33%
Revenue NY rev (3m)-0.56%
Valuation
Industry RankSector Rank
PE 33.31
Fwd PE 26.55
P/S 3.86
P/FCF 64.93
P/OCF 41.71
P/B 4.79
P/tB N/A
EV/EBITDA 21.04
EPS(TTM)8.3
EY3%
EPS(NY)10.42
Fwd EY3.77%
FCF(TTM)4.26
FCFY1.54%
OCF(TTM)6.63
OCFY2.4%
SpS71.67
BVpS57.78
TBVpS-8.74
PEG (NY)2.47
PEG (5Y)1.98
Graham Number103.873 (-62.43%)
Profitability
Industry RankSector Rank
ROA 3.47%
ROE 7.69%
ROCE 10.25%
ROIC 8.26%
ROICexc 8.88%
ROICexgc 23.79%
OM 16.32%
PM (TTM) 6.2%
GM 41.03%
FCFM 5.94%
ROA(3y)8.13%
ROA(5y)6.95%
ROE(3y)14.16%
ROE(5y)12.39%
ROIC(3y)9.23%
ROIC(5y)9.14%
ROICexc(3y)11.13%
ROICexc(5y)10.9%
ROICexgc(3y)24.2%
ROICexgc(5y)23.61%
ROCE(3y)11.44%
ROCE(5y)11.33%
ROICexgc growth 3Y-4.81%
ROICexgc growth 5Y4.33%
ROICexc growth 3Y-13.9%
ROICexc growth 5Y-0.62%
OM growth 3Y4.27%
OM growth 5Y6.87%
PM growth 3Y-5.45%
PM growth 5Y16.13%
GM growth 3Y2.82%
GM growth 5Y2.28%
F-Score7
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF 10.36
Debt/EBITDA 2.95
Cap/Depr 72.43%
Cap/Sales 3.31%
Interest Coverage 4.14
Cash Conversion 44.28%
Profit Quality 95.79%
Current Ratio 2.87
Quick Ratio 2.1
Altman-Z 4.5
F-Score7
WACC10.31%
ROIC/WACC0.8
Cap/Depr(3y)79.12%
Cap/Depr(5y)76.65%
Cap/Sales(3y)3.23%
Cap/Sales(5y)3.25%
Profit Quality(3y)73.62%
Profit Quality(5y)95.61%
High Growth Momentum
Growth
EPS 1Y (TTM)16.41%
EPS 3Y10.17%
EPS 5Y16.81%
EPS Q2Q%8.9%
EPS Next Y13.51%
EPS Next 2Y15.19%
EPS Next 3Y19.31%
EPS Next 5YN/A
Revenue 1Y (TTM)21.02%
Revenue growth 3Y2.42%
Revenue growth 5Y5.5%
Sales Q2Q%16.6%
Revenue Next Year14.84%
Revenue Next 2Y10.37%
Revenue Next 3Y9.3%
Revenue Next 5YN/A
EBIT growth 1Y31.68%
EBIT growth 3Y6.8%
EBIT growth 5Y12.75%
EBIT Next Year41.74%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-36.81%
FCF growth 3Y-8.49%
FCF growth 5Y9.91%
OCF growth 1Y-22.37%
OCF growth 3Y-3.61%
OCF growth 5Y8.06%

STANDEX INTERNATIONAL CORP / SXI Fundamental Analysis FAQ

What is the fundamental rating for SXI stock?

ChartMill assigns a fundamental rating of 5 / 10 to SXI.


What is the valuation status of STANDEX INTERNATIONAL CORP (SXI) stock?

ChartMill assigns a valuation rating of 2 / 10 to STANDEX INTERNATIONAL CORP (SXI). This can be considered as Overvalued.


How profitable is STANDEX INTERNATIONAL CORP (SXI) stock?

STANDEX INTERNATIONAL CORP (SXI) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for SXI stock?

The Price/Earnings (PE) ratio for STANDEX INTERNATIONAL CORP (SXI) is 33.31 and the Price/Book (PB) ratio is 4.79.


Can you provide the financial health for SXI stock?

The financial health rating of STANDEX INTERNATIONAL CORP (SXI) is 5 / 10.